• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)中肺功能测试的挑战与未来:迈向COPD的早期诊断

Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD.

作者信息

Kim Sang Hyuk, Han MeiLan K

机构信息

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.

出版信息

Tuberc Respir Dis (Seoul). 2025 Jul;88(3):413-418. doi: 10.4046/trd.2025.0009. Epub 2025 Mar 25.

DOI:10.4046/trd.2025.0009
PMID:40129308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12235289/
Abstract

In the field of chronic obstructive pulmonary disease (COPD), there is growing interest in methods for early detection with the goal of altering disease progression. At the same time, pulmonary function test (PFT) remains central to the diagnosis and management of COPD. Yet, spirometry remains underused, particularly in primary care, contributing to the underdiagnosis and misdiagnosis of COPD. Challenges hindering more aggressive use of spirometry include a lack of access in primary care clinics or public venues, the complexity of performing spirometry and a lack of comfort with interpretation. Enhancing PFT utilization will require new approaches including broadening availability and adopting different approaches to interpretation.

摘要

在慢性阻塞性肺疾病(COPD)领域,人们对旨在改变疾病进展的早期检测方法的兴趣日益浓厚。与此同时,肺功能测试(PFT)仍然是COPD诊断和管理的核心。然而,肺量计的使用仍然不足,尤其是在初级保健中,这导致了COPD的诊断不足和误诊。阻碍更积极使用肺量计的挑战包括在初级保健诊所或公共场所无法使用、进行肺量计检查的复杂性以及对解读结果缺乏信心。提高PFT的利用率将需要新的方法,包括扩大可及性和采用不同的解读方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce32/12235289/b229a8a29d9f/trd-2025-0009f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce32/12235289/7079df68bf77/trd-2025-0009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce32/12235289/b229a8a29d9f/trd-2025-0009f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce32/12235289/7079df68bf77/trd-2025-0009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce32/12235289/b229a8a29d9f/trd-2025-0009f2.jpg

相似文献

1
Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD.慢性阻塞性肺疾病(COPD)中肺功能测试的挑战与未来:迈向COPD的早期诊断
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):413-418. doi: 10.4046/trd.2025.0009. Epub 2025 Mar 25.
2
Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care.针对初级保健中管理慢性阻塞性肺疾病的卫生专业人员的教育干预措施。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD012652. doi: 10.1002/14651858.CD012652.pub2.
3
Mobile Phone Auscultation Accurately Diagnoses Chronic Obstructive Pulmonary Disease Using Nonlinear Respiratory Biofluid Dynamics.手机听诊利用非线性呼吸生物流体动力学准确诊断慢性阻塞性肺疾病。
Diagnostics (Basel). 2025 Jun 18;15(12):1550. doi: 10.3390/diagnostics15121550.
4
Evaluation of a Novel eHealth Tool for Pulmonary Rehabilitation in People With Chronic Obstructive Pulmonary Disease: Randomized Controlled Pilot and Feasibility Trial.一种用于慢性阻塞性肺疾病患者肺康复的新型电子健康工具的评估:随机对照试点及可行性试验。
JMIR Form Res. 2025 Jun 23;9:e68195. doi: 10.2196/68195.
5
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
6
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
7
Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease Among Users of Primary Health Care Facilities in Morocco.摩洛哥初级保健机构使用者中慢性阻塞性肺疾病的患病率及危险因素。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 5;19:375-387. doi: 10.2147/COPD.S443081. eCollection 2024.
8
Self-management education for patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的自我管理教育
Cochrane Database Syst Rev. 2007 Oct 17(4):CD002990. doi: 10.1002/14651858.CD002990.pub2.
9
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表:Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
10
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.

引用本文的文献

1
Impact of Low Hand Grip Strength on Quality of Life, Utilization of Healthcare, and Mental Health in Individuals with Airflow Limitation.低握力对气流受限个体生活质量、医疗保健利用及心理健康的影响
Int J Chron Obstruct Pulmon Dis. 2025 Jul 4;20:2199-2210. doi: 10.2147/COPD.S510974. eCollection 2025.

本文引用的文献

1
Diagnosis and evaluation of small airway disease and COPD using impulse oscillometry.使用脉冲震荡技术诊断和评估小气道疾病和 COPD。
Sci Rep. 2024 Nov 14;14(1):28030. doi: 10.1038/s41598-024-79818-w.
2
Beyond the Spirometry: New Diagnostic Modalities in Chronic Obstructive Pulmonary Disease.超越肺量计:慢性阻塞性肺疾病的新诊断方法
Tuberc Respir Dis (Seoul). 2025 Jan;88(1):1-13. doi: 10.4046/trd.2024.0040. Epub 2024 Sep 23.
3
Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial.慢性阻塞性肺疾病和哮喘的早期诊断和治疗 - 一项随机对照试验。
N Engl J Med. 2024 Jun 13;390(22):2061-2073. doi: 10.1056/NEJMoa2401389. Epub 2024 May 19.
4
Forced Expiratory Volume in One Second Quotient (FEV1Q) as a Prognostic Factor in Amyotrophic Lateral Sclerosis Patients: Comparing Its Predictive Value to Other Lung Function Measurements.一秒用力呼气容积商(FEV1Q)作为肌萎缩侧索硬化症患者的预后因素:将其预测价值与其他肺功能测量指标进行比较。
Cureus. 2024 Feb 14;16(2):e54176. doi: 10.7759/cureus.54176. eCollection 2024 Feb.
5
FEVQ: a race-neutral approach to assessing lung function.FEVQ:一种评估肺功能的种族中立方法。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.01622-2023. Print 2024 Apr.
6
Spirometric Interpretation and Clinical Relevance According to Different Reference Equations.根据不同的参考方程进行肺量计解读和临床相关性评估。
J Korean Med Sci. 2024 Jan 29;39(4):e20. doi: 10.3346/jkms.2024.39.e20.
7
Oscillometry-Defined Small Airway Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者中振荡法定义的小气道功能障碍
Tuberc Respir Dis (Seoul). 2024 Apr;87(2):165-175. doi: 10.4046/trd.2023.0139. Epub 2024 Jan 16.
8
Dysanapsis as a Determinant of Lung Function in Development and Disease.发育及疾病中肺功能的决定因素——发育不全
Am J Respir Crit Care Med. 2023 Nov 1;208(9):956-963. doi: 10.1164/rccm.202306-1120PP.
9
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.2020-50 年全球 204 个国家和地区慢性阻塞性肺疾病的全球经济负担:一项健康增强型宏观经济建模研究。
Lancet Glob Health. 2023 Aug;11(8):e1183-e1193. doi: 10.1016/S2214-109X(23)00217-6.
10
Gut microbiota and chronic obstructive pulmonary disease: a Mendelian randomization study.肠道微生物群与慢性阻塞性肺疾病:一项孟德尔随机化研究
Front Microbiol. 2023 Jun 19;14:1196751. doi: 10.3389/fmicb.2023.1196751. eCollection 2023.